Related Experiment Video

Updated: Jan 9, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Reply to: Deep Learning to Differentiate Parkinsonian Syndromes: From Proof of Concept to Clinical Trust

Giulia Maria Mattia1, Lydia Chougar2,3, Alexandra Foubert-Samier4,5,6

  • 1Univ Toulouse, Inserm, ToNIC, Toulouse, France.

Movement Disorders : Official Journal of the Movement Disorder Society
|December 5, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.0K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.0K

Related Experiment Videos

Last Updated: Jan 9, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.0K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.0K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

Articles linked to this work by shared authors, journal, and citation graph.

Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-Associated Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Clinical trials in late-stage Parkinson's disease.

Journal of Parkinson's disease·2026

Speech glottal flow performance in early stages of Parkinson's disease and multiple systems atrophy.

Journal of communication disorders·2026

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts.

Neurology·2026

Fifteen-Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society·2026

Distinct roles of the human cuneiform and pedunculopontine nuclei in gait and freezing of gait.

Brain : a journal of neurology·2026

Directional Adaptive Deep Brain Stimulation: An Initial Report of Safety, Tolerability, and Effectiveness.

Movement disorders : official journal of the Movement Disorder Society·2026

α-Synuclein Seeding Discriminates Between LRRK2 G2019S Variant Carriers with and Without Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Structural Brain and Spinal Cord Signature of Spinocerebellar Ataxia 27B: A Multisite MRI-Based Study.

Movement disorders : official journal of the Movement Disorder Society·2026

Lewy Body Disease Across Aging: Clinical and Neuropathological Correlates in a Population Brain Bank.

Movement disorders : official journal of the Movement Disorder Society·2026

Multimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia.

Movement disorders : official journal of the Movement Disorder Society·2026

Bromazepam distribution in a solid dosage form studied by time-of-flight secondary ion mass spectrometry.

Analytical methods : advancing methods and applications·2026

A Comparative Cost-Consequence Analysis of Spinal Cord Stimulation and Magnetic Peripheral Nerve Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy in an Integrated Health System.

Journal of pain research·2026

Application of an Open-Source Modular Framework for Pharmacokinetic, Pharmacodynamic, and Safety Simulations to Anti-Tuberculosis Drugs.

CPT: pharmacometrics & systems pharmacology·2026

Utilization of Brain Physiologically Based Pharmacokinetic Modeling in Support of CNS Drug Development: Case Example of Fenebrutinib.

The AAPS journal·2026

Engineering human multi-organ tissue chip niches for drug absorption, distribution, metabolism, excretion and toxicity prediction.

Nature biomedical engineering·2026

Regulatory sandboxes for drug development: from uncertainty to structured evidence generation.

Drug discovery today·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us